National Healthcare
175 hedge funds and large institutions have $917M invested in National Healthcare in 2024 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 60 increasing their positions, 66 reducing their positions, and 19 closing their positions.
32% more first-time investments, than exits
New positions opened: 25 | Existing positions closed: 19
16% more capital invested
Capital invested by funds: $789M → $917M (+$127M)
3% more funds holding
Funds holding: 170 → 175 (+5)
0.41% more ownership
Funds ownership: 54.49% → 54.91% (+0.41%)
9% less repeat investments, than reductions
Existing positions increased: 60 | Existing positions reduced: 66
Top Buyers
Top Sellers
| 1 |
BlackRock
New York
|
-$3.23M |
| 2 |
DZ Bank
Frankfurt Am Main,
Germany
|
-$1.95M |
| 3 |
State Street
Boston,
Massachusetts
|
-$1.95M |
| 4 |
State Board of Administration of Florida Retirement System
Tallahassee,
Florida
|
-$1.79M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
-$1.68M |
NHC Hedge Fund Activity: Q2 2024 in Review
175 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in National Healthcare (NHC) for Q2 2024, worth a combined $917M — up 16% from $789M a quarter earlier.
Buyers outnumbered sellers: 25 funds opened new NHC positions and 19 closed out — a net gain of 6 holders — while 60 added to existing stakes and 66 trimmed.
The largest buyer was Victory Capital Management, adding an estimated $4.7M. The largest seller was BlackRock, cutting an estimated $3.23M.
- 175 institutional investors held National Healthcare (NHC) as of Q2 2024, up from 170 in Q1 2024.
- Funds reported $917M of National Healthcare stock for Q2 2024, up 16% quarter-over-quarter.
- 25 funds opened new National Healthcare positions in Q2 2024 and 19 closed out, a net change of +6 holders.
- The largest National Healthcare buyer in Q2 2024 was Victory Capital Management, an estimated $4.7M added.
- The largest National Healthcare seller in Q2 2024 was BlackRock, an estimated $3.23M sold.
Based on aggregated 13F filings for Q2 2024.